Some evidence suggests that the OGFr may be markedly reduced in human head and neck squamous cell carcinoma, with tumor tissue exhibiting ninefold fewer OGFr binding sites and a fivefold reduction in OGFr protein levels compared to controls [27], thus claiming a dysregulation of this modulatory pathway in cancer disease progression [23,28]. This evidence concerns the gene OGFR and cancer.